How 140 Pharma Commercial Users Gained Direct Access to Decision-Ready Insights

The Problem

The client had done the right things: Veeva CRM, a centralized data warehouse, and Tableau dashboards. The infrastructure investment was real. The return was not.

Regional business managers were waiting 3–5 days for analyst-generated reports to answer questions about HCP prescription trends, campaign attribution, and rep performance. By the time a report arrived, the question had already driven a decision or been set aside. At the executive level, Tableau adoption was low because dashboards required specialist knowledge to navigate and interpret correctly.

The result: resource reallocation and HCP targeting decisions were being made on stale data, by people who lacked the tools to query fresh data themselves.

What Evalueserve Did

Evalueserve implemented PharmaGenAI across the client's commercial data estate — integrating directly with Veeva CRM, the cloud data warehouse, and existing Tableau infrastructure. No custom model training was required. The platform was configured to the client's brand portfolio (two dermatology assets, one immunology product) and deployed via the NexusBot natural language interface to 140 commercial users across sales, marketing, and regional business management.

Users could query TRx trends, HCP engagement history, campaign ROI, and rep access patterns in plain language. The query-to-answer cycle no longer routed through an analyst queue.

ML models embedded in the platform enabled what-if scenario analysis. Regional managers could model the impact of territory restructuring before committing to reallocation decisions — a capability that previously required a bespoke analyst engagement.

The Results

Within 90 days: 5× reduction in time-to-insight, with the average query-to-answer cycle dropping from 3–5 days to under 4 hours. Executive BI adoption increased by 50%. Field force call planning quality improved measurably as NexusBot-generated HCP prioritization lists replaced static decile rankings.

The client has since initiated a Phase 2 expansion to include market access and payer analytics within the same query interface.

Why This Matters

The bottleneck in most pharma commercial operations is not data. It's access to data at the speed decisions are made. Dashboards that require specialist interpretation are not decision tools — they are reporting tools that sit between the data and the person who needs it.

The right question is not whether the data is available. It's whether the people making territory, HCP, and resource decisions can get answers in the same meeting where the question is asked. PharmaGenAI changes that without replacing the data infrastructure the client already has.

Talk to One of Our Experts

Get in touch today to find out about how Evalueserve can help you improve your processes, making you better, faster and more efficient. 

Overview & Impact

A specialty pharmaceutical company partnered with Evalueserve to give 140 commercial users direct access to insights across its CRM, data warehouse, and BI environment. PharmaGenAI reduced reliance on analyst reports and accelerated decisions on HCP targeting, campaign performance, and field activity.

0 x

Faster Time to Insight

0 %

Higher Executive BI Adoption

Share: